- Home
- CNVS vs NSPR Comparison
CNVS vs NSPR Comparison
Compare CNVS & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNVS
- NSPR
- Stock Information
- Founded
- CNVS 2000
- NSPR 2005
- Country
- CNVS United States
- NSPR Israel
- Employees
- CNVS N/A
- NSPR N/A
- Industry
- CNVS Consumer Electronics/Video Chains
- NSPR Medical/Dental Instruments
- Sector
- CNVS Consumer Discretionary
- NSPR Health Care
- Exchange
- CNVS Nasdaq
- NSPR Nasdaq
- Market Cap
- CNVS 56.2M
- NSPR 63.0M
- IPO Year
- CNVS 2003
- NSPR N/A
- Fundamental
- Price
- CNVS $3.54
- NSPR $2.72
- Analyst Decision
- CNVS Buy
- NSPR Strong Buy
- Analyst Count
- CNVS 1
- NSPR 2
- Target Price
- CNVS $10.00
- NSPR $4.75
- AVG Volume (30 Days)
- CNVS 104.5K
- NSPR 27.8K
- Earning Date
- CNVS 02-12-2025
- NSPR 03-05-2025
- Dividend Yield
- CNVS N/A
- NSPR N/A
- EPS Growth
- CNVS N/A
- NSPR N/A
- EPS
- CNVS N/A
- NSPR N/A
- Revenue
- CNVS $45,005,000.00
- NSPR $6,821,000.00
- Revenue This Year
- CNVS $50.96
- NSPR $13.36
- Revenue Next Year
- CNVS N/A
- NSPR $49.64
- P/E Ratio
- CNVS N/A
- NSPR N/A
- Revenue Growth
- CNVS N/A
- NSPR 24.70
- 52 Week Low
- CNVS $0.72
- NSPR $1.81
- 52 Week High
- CNVS $4.19
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- CNVS 49.00
- NSPR 47.01
- Support Level
- CNVS $3.34
- NSPR $2.50
- Resistance Level
- CNVS $3.60
- NSPR $2.83
- Average True Range (ATR)
- CNVS 0.23
- NSPR 0.20
- MACD
- CNVS -0.05
- NSPR -0.01
- Stochastic Oscillator
- CNVS 28.57
- NSPR 41.54
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.